I don't think it is a sign they are in trouble. Everything is for sale if the price is right. It would be up to management to ensure they didn't recommend any low ball offers. I think ultimately they would be best to sell once P3 results are in to get max $, otherwise the risk of failure weighs on the transaction price.
I can't see it happening personally with 1/2 the business already licensed. My prediction is the deal will be done with Acadia in the end, but Neuren are going to hold their feet to the fire and ensure a suitable deal. Neuren need to establish the market value of a ROW deal - it's a bit hard to know where this all sits.
NEU Price at posting:
$1.15 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)